Trial intelligence / Profile preview

Myfortic Combined With Low-dose Steroid in MCNS

NCT01185197Phase 4Completed

Sponsor
The University of Hong Kong
Start
Sep 2010
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate sodium in nephrosis, sponsored by The University of Hong Kong. Started Sep 2010; status: completed.

02

Drugs

mycophenolate sodium
03

Conditions

nephrosis

Beyond the preview

Go deeper on NCT01185197.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01185197.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call